Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3108980 | 0.79 | ACHE (0.39) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL3339303 | 0.73 | NLRP3 (0.33) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL17805213 | 0.72 | KDM4E (0.31) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL13027094 | 0.70 | ACHE (0.52) | KDM4EALDH1A1LMNAMAPTACHE | |
| SCHEMBL13295957 | 0.69 | RAPGEF4 (0.41) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL13296036 | 0.69 | RAPGEF4 (0.41) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL1314789 | 0.67 | RAPGEF4 (0.39) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL4464617 | 0.67 | RAPGEF4 (0.39) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL297423 | 0.67 | RAPGEF4 (0.39) | RAPGEF4KDM4EALDH1A1LMNAGAA | |
| SCHEMBL1686911 | 0.67 | ALDH1A1 (0.44) | RAPGEF4KDM4EALDH1A1LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1782436-B1 | METHOD FOR TREATING ELECTRICAL CABLE AT SUSTAINED ELEVATED PRESSURE | NOVINIUM INC (US) | 2017-05-31 | — | — | EP | disclosed |
| US-9170492-B2 | Silicon-containing film-forming composition, silicon-containing film, and pattern forming method | JSR CORPORATION (JP) | 2015-10-27 | — | — | US | disclosed |
| US-9140985-B2 | — | — | 2015-09-22 | — | — | US | disclosed |
| US-8968458-B2 | Composition for resist underlayer film and process for producing same | JSR CORPORATION (JP) | 2015-03-03 | — | — | US | disclosed |
| US-8808446-B2 | Composition for resist underlayer film and process for producing same | JSR CORPORATION (JP) | 2014-08-19 | — | — | US | disclosed |
| EP-2121273-B1 | ACID-CATALYZED DIELECTRIC ENHANCEMENT FLUID AND CABLE RESTORATION METHOD EMPLOYING SAME | NOVINIUM INC (US) | 2014-06-25 | — | — | EP | disclosed |
| US-8656586-B2 | Method for treating electrical cable at sustained elevated pressure | NOVINIUM, INC. (US) | 2014-02-25 | — | — | US | disclosed |
| EP-1744866-B1 | METHOD FOR SELECTING FORMULATIONS TO TREAT ELECTRICAL CABLES | NOVINIUM INC (US) | 2012-08-08 | — | — | EP | disclosed |
| US-8205326-B2 | Method for treating electrical cable at sustained elevated pressure | NOVINIUM, INC. (US) | 2012-06-26 | — | — | US | disclosed |
| US-20120102729-A1 | METHOD FOR TREATING ELECTRICAL CABLE AT SUSTAINED ELEVATED PRESSURE | NOVINIUM, INC. (US) | 2012-05-03 | — | — | US | disclosed |
| US-20090023855-A1 | NOVEL CURABLE RESIN, PRODUCTION METHOD THEREOF, EPOXY RESIN COMPOSITION, AND ELECTRONIC DEVICE | RESONAC CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| US-20080249326-A1 | High-Endurance Packing Material for Liquid Chromatography | DAISO CO., LTD (JP) | 2008-10-09 | — | — | US | disclosed |
| US-20080173467-A1 | ACID-CATALYZED DIELECTRIC ENHANCEMENT FLUID AND CABLE RESTORATION METHOD EMPLOYING SAME | NOVINIUM, INC. (US) | 2008-07-24 | — | — | US | disclosed |
| EP-1855159-A1 | COMPOSITION FOR UNDERLAYER FILM OF RESIST AND PROCESS FOR PRODUCING THE SAME | JSR Corporation (JP) | 2007-11-14 | — | — | EP | disclosed |
| US-20050192708-A1 | Method for selecting formulations to treat electrical cables | NOVINIUM, INC. (US) | 2005-09-01 | — | — | US | disclosed |
| US-20050189130-A1 | Method for treating electrical cable at sustained elevated pressure | NOVINIUM, INC. (US) | 2005-09-01 | — | — | US | disclosed |
| US-6433119-B1 | COORDINATION CATALYST ON CATALYST SUPPORT | BASELL POLIOLEFINE ITALIA S.P.A. (IT) | 2002-08-13 | — | — | US | disclosed |
| US-6054406-A | ZIEGLER-NATTA CATALYST FOR POLYMERIZING ALPHA-OLEFIN | MONTELL NORTH AMERICA INC. (US) | 2000-04-25 | — | — | US | disclosed |
| EP-0423786-B1 | Polymetallic catalysts, method of preparing and polymers produced thereby | MONTELL NORTH AMERICA INC (US) | 1998-12-16 | — | — | EP | disclosed |
| EP-0423786-A2 | Polymetallic catalysts, method of preparing and polymers produced thereby | MONTELL NORTH AMERICA INC. (US) | 1991-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080249326-A1 | High-Endurance Packing Material for Liquid Chromatography | CCL2, CCR2, CX3CR1 | RAPGEF4 2346/4885KDM4E 647/4885ALDH1A1 257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.